Foreign body granuloma at the exit site in patients on CAPD: Use of 1% gentian violet as topical treatment

Peritoneal Dialysis International

Volumn 17, Issue 5, 1997, Pages 509-511

  Moysés Neto, Miguel ^a   Cherubini, Álvaro ^a   Nardim Batista, Maria E ^a   Raspanti, Edmundo Octavio ^a   Vieira Neto, Osvaldo M ^a   Nakagawa, Beatriz ^a   Conceição, Ana M R ^a   Bittar Feres, Mara R ^a   Infantosi Vannucchi, Maria T ^a  

^a HOSPITAL SÃO FRANCISCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CRYSTAL VIOLET;

ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CAUTERIZATION; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DRY SKIN; FOREIGN BODY GRANULOMA; GRANULATION TISSUE; HEALTH CARE COST; HUMAN; KIDNEY FUNCTION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0030720312     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089701700515     Document Type: Article

References (6)

1. Moncrief JW, Popovich RP, Dombros NV, Digenis GE, Oreopoulos DG. Continuous ambulatory peritoneal dialysis. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. Dordrecht: Kluwer Academic, 1994:357-97.
2. Twardowski ZJ, Khanna R. Peritoneal dialysis access and exit site care. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. Dordrecht: Kluwer Academic, 1994:271-314.
3. Reynolds JEF. Gentian violet, topical solution 1%. In: Martindale, the extra pharmacopoeia. London: The Pharmaceutical Press, 1993.
4. Copley JB. Prevention of peritoneal dialysis catheter-related infections. Am J Kidney Dis 1987; X:401-7.
5. Prowant BF, Warady A, Nolph KD. Peritoneal dialysis catheter exit-care: results of an international survey. Pent Dial Int 1993; 13:149-54.
6. Gokal R, Ash SR, et al. Peritoneal catheters and exit-site practices: toward optimum peritoneal access. Perit Dial Int 1993; 13:29-39.